Pfizer Inc. (TSX:PFE)
12.23
+0.04 (0.33%)
Oct 6, 2026, 3:59 PM EST
Pfizer Employees
Pfizer had 75,000 employees as of December 31, 2025. The number of employees decreased by 6,000 or -7.41% compared to the previous year.
Employees
75,000
Change (1Y)
-6,000
Growth (1Y)
-7.41%
Revenue / Employee
1.20M CAD
Profits / Employee
81.99K CAD
Market Cap
222.89B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,000 | -6,000 | -7.41% |
| Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
| Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
| Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
| Dec 31, 2021 | 79,000 | 500 | 0.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Cronos Group | 610 |
Pfizer News
- 6 hours ago - Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 - PRNewsWire
- 13 hours ago - Pfizer price target raised to $33 from $30 at Scotiabank - TheFly
- 16 hours ago - Pfizer Declares Fourth-Quarter 2026 Dividend - Business Wire
- 4 days ago - Pfizer says LITFULO significantly improved repigmentation in patients - TheFly
- 4 days ago - Pfizer's LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo - Business Wire
- 5 days ago - Trump Medicare drug pricing model may apply to only four companies after exemptions - Reuters
- 5 days ago - Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims - Reuters
- 5 days ago - Florida sues Pfizer over COVID vaccine marketing - TheFly